Erlocip 150 mg
Discontinued | No |
---|---|
USA Brand | Taceva |
SKU | ODP1802 |
Details
SKU No. | ODP1802 |
USA Brand Name | Tarceva |
Generic Name | Erlotinib |
Strength | 150mg |
Manufacturer | Cipla, India |
What is Erlocip 150
Erlocip 150 mg is used to treat Pancreatic or Non-Small Cell Lung Cancer.
Erlotinib is the active salt in this medication, which is a part of the Tyrosine Kinase Inhibitors (TKIs) group.
Cipla Limited manufactures Erlocip medication.
Uses of Erlocip 150 mg
Erlocip 150 treats:
- Non-Small Cell Lung Cancer (NSCLC): The most prevalent kind of lung cancer is NSCLC. When you have this condition, cancerous cells begin forming in your lungs' tissues.
- Pancreatic cancer: Pancreatic cancer develops in pancreatic cells. Cancer of the pancreas first develops in the tissues of the pancreas, which is an organ located in the abdomen and is situated behind the lower portion of the stomach.
How Erlocip works
Erlotinib is categorized as a Tyrosine Kinase Inhibitor (TKI), which inhibits the development of cancer cells.
It inhibits the transmembrane proteins on cancer cells that promote their growth.
These proteins are known as Epidermal Growth Factor Receptors (EGFR).
If your cancer carries these receptors, you have EGFR-positive cancer. Before receiving this treatment, your cancer cells are tested to see whether or not they contain these receptors.
Erlotinib in this medication can help reduce cancer or temporarily halt its growth.
Dosage
Take Erlotinib 150 precisely as prescribed by your healthcare provider.
You must strictly adhere to the dosage and frequency recommendations provided by your medical professional.
How to take Erlocip 150 mg
150 mg of Erlocip should be consumed by mouth.
Typically, it is taken once daily on an empty stomach, at least one hour before or two hours after a meal or snack.
Erlotinib should be taken daily at around the same time.
However, it would be best if you consume it as prescribed by your physician.
Missed dose
Take your next dosage at your usual time the next day. If you forget to take a dosage, you shouldn't take two at once to compensateit.
Overdose
In the case of an overdose, contact your healthcare provider immediately.
Strengths and Substitutes of Erlocip 150 tablet
Erlocip is manufactured in two strengths:
Substitutes
Alternatives to Erlocip containing the same salt, Erlotinib are:
Side effects of Erlocip 150 mg
Erlocip tablets can cause some mild to moderate side effects, such as:
- Diarrhea
- Weakness
- Loss of appetite
- Cough
- Rash
- Shortness of breath
- Fatigue
- Nausea
- Kidney problems
- Liver problems
- Bone or muscle pain
- Depression
- Anxiety
- Gastrointestinal Perforation
- Serious skin conditions
Interactions
This 150 mg pill of Erlotinib can cause some interactions with other medications, conditions, and food.
Drug interactions
Erlocip 150 can interact with the following drugs:
- Medications to lower stomach acid
- Antiplatelet medicines
- Blood thinners
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Aspirin
Disease interactions
If you have the following conditions consult your doctor before consuming this medication:
- Dermatologic Toxicities
- GI disorders
- Ocular disorders
- Pulmonary Toxicity
- Hepatic/Renal impairment
Food interactions
Grapefruit and grapefruit juice should also be avoided when using Erlotinib 150 mg. Grapefruit may increase the concentration of Erlocip in the body, resulting in more severe adverse effects.
Precautions
Before and after consuming this Erlocip remember the following points:
- If you are allergic to Erlotinib, you should not take this medication
- Erlotinib may produce a rash that develops or worsens under sunlight. If sun exposure causes a rash, avoid going outside
- Do not smoke when consuming Erlotinib. If you smoke, it may be necessary to modify your Erlotinib medication. If you smoke while taking Erlotinib, consult with your healthcare professional
- Erlocip 150 mg is known to cause damage to an unborn child. During therapy and for at least one month after the final dosage of Erlotinib, women should utilize an effective method of contraception
- Do not breastfeed during Erlocip treatment and for two weeks following the last dosage
Storage
Store 150 mg of Erlocip at room temperature and out of the reach of children.